---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-003071"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2023-01-11T23:59:59+00:00"
generated_at: "2026-06-20T16:39:55.721376+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# P3 Health reaffirms 2022 guidance, sees 2023 revenue $1.2B-$1.25B, narrower EBITDA loss

## Summary
- Reaffirmed FY2022 revenue $1.025B-$1.075B (61-69% YoY growth); at-risk MA membership >100k.
- FY2023 guidance: revenue $1.20B-$1.25B, membership 115k-120k, Adj. EBITDA loss $40M-$60M.
- Company anticipates achieving positive Adj. EBITDA in 2024.

## SEC filing metadata
- accession: 0001104659-23-003071
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2023-01-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/tm233132d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-003071
- JSON: https://secwatch.observer/filing/0001104659-23-003071.json
- Plain text: https://secwatch.observer/filing/0001104659-23-003071.txt

## Key facts
- Earnings Releases
  P3 Health Partners Inc. updated its full-year 2022 guidance (reaffirmed).
  - Period: full-year 2022
  - Guidance: reaffirmed
  - Result: guidance update
  source text: P3 is reaffirming full-year 2022 financial guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm
- Earnings Releases
  P3 Health Partners Inc. updated its full-year 2022 guidance (reaffirmed).
  - Period: full-year 2022
  - Guidance: reaffirmed
  - Result: guidance update
  source text: P3 is reaffirming the revenue guidance range given on the third quarter earnings call of between $1.025 billion and $1.075 billion
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm
- Earnings Releases
  P3 Health Partners Inc. updated its full-year 2023 guidance (initiated).
  - Period: full-year 2023
  - Guidance: initiated
  - Result: guidance update
  source text: announcing financial guidance for the full-year 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm
- Earnings Releases
  P3 Health Partners Inc. updated its full-year 2023 guidance (initiated).
  - Period: full-year 2023
  - Guidance: initiated
  - Result: guidance update
  source text: Revenue is expected to be in a range of $1.20 billion to $1.25 billion
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.